Previous 10 | Next 10 |
Gainers: Adagio (NASDAQ:ADGI) +101%. Kaixin (NASDAQ:KXIN) +34%. Calliditas (NASDAQ:CALT) +25%. Euro Tech Holdings (NASDAQ:CLWT) +19%. Mechel (NYSE:MTL) +17%. Processa (NASDAQ:PCSA) +17%. Versus Systems (NASDAQ:VS) +17%. Assertio (NASDAQ:ASRT) +17%. Zai Lab (NASDAQ:ZLAB) +17%. Petros Pharmaceu...
Shares of Adagio Therapeutics (ADGI +63.8%) are surging in morning trading after a Jefferies analyst said that pre-print data suggests that its COVID-19 antibody ADG20 retains neutralization activity against the Omicron variant. Michael Yee cited independent labs -- one at Columbia University...
Gainers: Adagio Therapeutics (NASDAQ:ADGI) +68%, Calliditas Therapeutics (NASDAQ:CALT) +28%, Assertio (NASDAQ:ASRT) +17%, Aptose Biosciences (NASDAQ:APTO) +16%, Arcturus Therapeutics (NASDAQ:ARCT) +15%. Losers: uniQure (NASDAQ:QURE) -25%, Regi...
Adagio Therapeutics (NASDAQ: ADGI) stock is getting beaten down again after a lousy day on Tuesday. Disappointing news regarding the clinical-stage biotechnology company's lead candidate, ADG20, pushed the stock 19.4% lower as of 1:14 p.m. ET on Wednesday. Adagio Therapeutics' l...
Gainers: Biofrontera (NASDAQ:BFRI) +26%, Gemini Therapeutics (NASDAQ:GMTX) +19%, Vir Biotechnology (NASDAQ:VIR) +14%, Mesoblast (NASDAQ:MESO) +14%, Tandem Diabetes Care (NASDAQ:TNDM) +10% Losers: Atai Life Sciences (NASDAQ:ATAI) -24%, Alzamend...
After losing over three-quarters of its market cap Tuesday on the news of the limited neutralization effect of its experimental COVID-19 therapy ADG20 against Omicron, Adagio Therapeutics (NASDAQ:ADGI) has shed another ~6.6% in the pre-market as Wall Street weigh its impact on the stock. In r...
Chinese real estate stocks were among the leaders to the downside during Tuesday's weak session on Wall Street. Concerns surrounding Shimao Group (OTCPK:SIOPF) sparked losses across the industry, including notable retreats from Nam Tai Property (NYSE:NTP) and MDJM (NASDAQ:MDJH). The drug deve...
Adagene (ADAG +9.5%) shares are up today after the small biotech had two posters at the American Society of Hematology Annual Meeting on AD152 and AD153. AD152 is a CD20xCD3 bispecific T-cell engager, while AD153 is an anti-CD47 monoclonal antibody. Both are designed as anti-tumor therapies a...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips The omicron variant has sent several biotech companies higher as investors speculate which company will develop an effective vaccine against the new variant. However, shareholders in Adagio Therapeutics (NASDAQ: ADGI ...
Gainers: Galera Therapeutics (NASDAQ:GRTX) +106%. Nuverra Environmental Solutions (NYSE:NES) +33%. CPS Technologies (NASDAQ:CPSH) +24%. Terminix (NYSE:TMX) +21%. Alzamend Neuro (NASDAQ:ALZN) +17%. MIND Technology (NASDAQ:MIND) +17%. Landec Corporation (NASDAQ:LNDC) +13%. Soliton (NASDAQ:SOLY)...
News, Short Squeeze, Breakout and More Instantly...
Adagio Therapeutics Inc. Company Name:
ADGI Stock Symbol:
NASDAQ Market:
WALTHAM, Mass., July 01, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that as part of the annual reconstitution of the Russell stock indexes, Invivyd will be included in ...
Pseudovirus in vitro neutralization data show continued neutralizing activity of VYD222 (pemivibart) against the KP.1.1 FLiRT and KP.3 SARS-CoV-2 variants, virus selections representative of current dominant strains and the most recent FLiRT-containing viruses Invivyd’s new data is...
WALTHAM, Mass., June 03, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that its management team is scheduled to participate in a fireside chat at the Jefferies Global Heal...